2016-03-07T00:00:00.000-05:00
pancreatic cancer,-0.396304
Buy rating,0.213883
tarextumab program,-0.396304
price target,0.213883
recovery,0.499876
great entry point,0.499876
biosimilar delays,-0.360267
Johnson,0.233877
Piper Jaffray analyst,-0.396304
Edward Tenthoff,-0.396304
metrics,-0.579081
AbbVie,0.213883
stock price,0.499876
Sanofi,-0.235321
